557 — China Tian Yuan Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- HK$311.20m
- HK$302.23m
- HK$26.85m
Annual cashflow statement for China Tian Yuan Healthcare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -126 | -19.1 | -40.3 | -28.8 | -38.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 66.9 | -11.7 | 2.45 | 0.199 | 12.5 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 90.4 | 35.2 | -1.99 | 24.6 | 28.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 52.6 | 16.3 | -30.4 | 5.1 | 10.7 |
| Capital Expenditures | -0.336 | -1.46 | -1.35 | -0.595 | -0.017 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -10.9 | 0.042 | 0.115 | 0.959 | 0.014 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -11.2 | -1.42 | -1.23 | 0.364 | -0.003 |
| Financing Cash Flow Items | -2.54 | -4.49 | -3.96 | -3.54 | -3.22 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.58 | -7.22 | -12.5 | -8.77 | -10.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 35.8 | 7.52 | -39.2 | -5.62 | 3.44 |